行情中心 沪深京A股 上证指数 板块行情 股市异动 专题 涨跌情报站 盯盘 港股 研究所 直播 股票开户 智能选股
全球指数
数据中心 资金流向 龙虎榜 融资融券 沪深港通 比价数据 研报数据 公告掘金 新股申购 大宗交易 业绩速递

INNOLIGHT(300308):1Q26 EARNINGS:BRIGHTER THAN A SHOOTING STAR

招银国际证券有限公司 04-17 00:00

Innolight delivered a standout 1Q26, with revenue jumping 192% YoY / 47.3% QoQ to RMB19.5bn (vs. Bloomberg consensus of RMB15.4bn), and net profit surging 262% YoY / 56.5% QoQ to RMB5.7bn (vs. RMB4.4bn consensus), both marking new quarterly highs. During the period, GPM expanded further to 46.1% (vs. 44.5% in 4Q25), primarily due to improving mix and rising SiPho penetration. Mgmt. framed the strong quarter not as a one-off outperformance but as a reflection of sustained demand strength and improved execution, with robust capacity ramp-up, including Thailand, and resilient raw material procurement supporting shipment in a tight S/D backdrop. Maintain BUY with TP adjusted to RMB1,080 on 28x rollover 2027E P/E (prev. 28x 2026E P/E).

800G and 1.6T ramped up in tandem, with rising SiPho mix further lifting margin. Revenue strength was driven by concurrent ramp-up in both 800G and 1.6T products, indicating that growth is broadening across the company’s high-end optical portfolio rather than being tied to a single product inflection. Mgmt. highlighted meaningful contribution from both 800G and 1.6T shipments in 1Q26, with the richer product mix continuing to drive margin higher. Within 1.6T, SiPho is expected to account for more than half of shipments this year, reinforcing our view that rising SiPho penetration should remain an important structural support to margin.

NPO is the earlier catalyst, while XPO provides broader deployment flexibility. Mgmt. indicated NPO has already received explicit customer demand indications and could enter volume production in 2027, with the use case tied primarily to scale-up architectures. XPO, by contrast, is still in active customer promotion, but was positioned across both scale-up and scale-out scenarios, with transmission reach of roughly 100m to 2km, implying broader deployment potential once commercialization visibility improves.

Maintain BUY with TP revised to RMB1,080 on rollover 28x 2027E P/E, supported by an order backlog that now stretches through 2026 and into 2027 (and even beyond). In our view, what stood out this quarter was not only the magnitude of the beat, but the quality of execution behind it: Capacity expansion landed on time, supply-chain preparation remained effective despite tight upstream conditions, while product mix was moving structurally upward. We believe this supports a more durable earnings profile and strengthens confidence that Innolight can capture incremental upside from future architectural shifts.

免责声明:以上内容仅供您参考和学习使用,任何投资建议均不作为您的投资依据;您需自主做出决策,自行承担风险和损失。九方智投提醒您,市场有风险,投资需谨慎。

相关股票

相关板块

  • 板块名称
  • 最新价
  • 涨跌幅

相关资讯

扫码下载

九方智投app

扫码关注

九方智投公众号

头条热搜

涨幅排行榜

  • 上证A股
  • 深证A股
  • 科创板
  • 排名
  • 股票名称
  • 最新价
  • 涨跌幅
  • 股圈